Regular therapy is recommended for sustained long-term results
These two pathways converge
Clinicians must carefully evaluate individual patient risk factors, particularly personal or family history of MTC or multiple endocrine neoplasia syndrome type 2 (MEN 2), before prescribing these agents
A 2016 systematic review and meta-analysis published in Obesity Reviews (Pooyandjoo et al.), which pooled data from nine randomised controlled trials, found that L-carnitine supplementation was associated with a statistically significant but modest reduction in body weight compared to placebo approximately 1.3 kg on average
It helps break the cycle of hunger, cravings, and overeating, replacing it with a sense of control and balance
As evidenced in the SURPASS trials, this novel GIP/GLP-1 dual-acting hormone therapy is yielding significant improvements in A1c and weight loss